Business Description
Foresee Pharmaceuticals Co Ltd
ISIN : TW0006576002
Description
Foresee Pharmaceuticals Co Ltd is engaged in the development and commercialization of new drugs using its proprietary drug delivery technology. Its main activity is to apply its Stabilized injectable formulation(SIF) platform technology to produce the products for anticancer and treatment of chronic disease. Its SIF product pipeline includes FP-001 for prostate cancer, FP-004 for Opioid drug addiction/Pain, FP-011 for Breast Cancer/Prostate Cancer, FP-016 for neurological diseases, and others. All of its revenue is generated from Taiwan.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.88 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | -0.3 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.1 | |||||
| Beneish M-Score | -1.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12 | |||||
| 3-Year EBITDA Growth Rate | -19.3 | |||||
| 3-Year EPS without NRI Growth Rate | -17.8 | |||||
| 3-Year FCF Growth Rate | -2.3 | |||||
| 3-Year Book Growth Rate | -16 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.86 | |||||
| 9-Day RSI | 34.78 | |||||
| 14-Day RSI | 42.79 | |||||
| 6-1 Month Momentum % | -20.32 | |||||
| 12-1 Month Momentum % | -3.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.67 | |||||
| Quick Ratio | 2.41 | |||||
| Cash Ratio | 2.14 | |||||
| Days Inventory | 290.67 | |||||
| Days Sales Outstanding | 71.41 | |||||
| Days Payable | 58.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.7 | |||||
| Shareholder Yield % | -1.42 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.98 | |||||
| Operating Margin % | -262.6 | |||||
| Net Margin % | -262.54 | |||||
| FCF Margin % | -251.93 | |||||
| ROE % | -63.5 | |||||
| ROA % | -44.87 | |||||
| ROIC % | -170.28 | |||||
| ROC (Joel Greenblatt) % | -438.2 | |||||
| ROCE % | -52.4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 33.11 | |||||
| PB Ratio | 10.9 | |||||
| Price-to-Tangible-Book | 12.38 | |||||
| EV-to-EBIT | -12.53 | |||||
| EV-to-EBITDA | -13.9 | |||||
| EV-to-Revenue | 30.72 | |||||
| EV-to-FCF | -12.56 | |||||
| Price-to-Net-Current-Asset-Value | 14.69 | |||||
| Price-to-Net-Cash | 22.72 | |||||
| Earnings Yield (Greenblatt) % | -7.97 | |||||
| FCF Yield % | -7.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Foresee Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 327.184 | ||
| EPS (TTM) (NT$) | -6.36 | ||
| Beta | 0.62 | ||
| Volatility % | 23.39 | ||
| 14-Day RSI | 42.79 | ||
| 14-Day ATR (NT$) | 1.326015 | ||
| 20-Day SMA (NT$) | 81.2 | ||
| 12-1 Month Momentum % | -3.65 | ||
| 52-Week Range (NT$) | 68.4 - 107.5 | ||
| Shares Outstanding (Mil) | 135.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Foresee Pharmaceuticals Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Foresee Pharmaceuticals Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Foresee Pharmaceuticals Co Ltd Frequently Asked Questions
What is Foresee Pharmaceuticals Co Ltd(ROCO:6576)'s stock price today?
The current price of ROCO:6576 is NT$80.20. The 52 week high of ROCO:6576 is NT$107.50 and 52 week low is NT$68.40.
When is next earnings date of Foresee Pharmaceuticals Co Ltd(ROCO:6576)?
The next earnings date of Foresee Pharmaceuticals Co Ltd(ROCO:6576) is .
Does Foresee Pharmaceuticals Co Ltd(ROCO:6576) pay dividends? If so, how much?
Foresee Pharmaceuticals Co Ltd(ROCO:6576) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers